These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6205938)

  • 41. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa.
    Johnston LJ; Syeklocha D
    Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185
    [No Abstract]   [Full Text] [Related]  

  • 42. Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.
    Young LS
    J Infect Dis; 1972 Sep; 126(3):277-87. PubMed ID: 4626510
    [No Abstract]   [Full Text] [Related]  

  • 43. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection.
    Montie TC; Drake D; Sellin H; Slater O; Edmonds S
    Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785
    [No Abstract]   [Full Text] [Related]  

  • 44. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
    [No Abstract]   [Full Text] [Related]  

  • 45. [The serological characteristics of the O antigens of Pseudomonas aeruginosa isolated from patients with a Pseudomonas infection during immunotherapy].
    Kholodkova EV; Krylov VM; Badikov VD; Sukhovskaia OA; Bazanova EB; Iushkova NA; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):59-61. PubMed ID: 1719718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of antibodies to Pseudomonas aeruginosa in patients with burns].
    Kolker II; Stanislavskiĭ ES; Zarubina EK; Grishina IA; Panova IuM
    Klin Med (Mosk); 1979 Nov; 57(11):77-81. PubMed ID: 120904
    [No Abstract]   [Full Text] [Related]  

  • 47. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
    Hoiby N; Mathiesen L
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 49. [Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations].
    Chekan LV; Min'ovich FL; Kutimova LR; Edvabnaia LS; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):85-9. PubMed ID: 6170196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice].
    Aleksandrova IA; Titova TI; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):46-50. PubMed ID: 2496541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
    Collins MS; Ladehoff D; Mehton NS
    Antibiot Chemother (1971); 1991; 44():185-95. PubMed ID: 1801636
    [No Abstract]   [Full Text] [Related]  

  • 53. Properties determining the potential of naturally occurring and vaccine-induced human antibodies to protect against lethal infection of Pseudomonas aeruginosa.
    Bruderer U; Fürer E; Cryz SJ; Lang AB
    Res Immunol; 1992 Feb; 143(2):165-74. PubMed ID: 1374194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
    Jones RJ; Roe EA
    Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific impairment of host defense for pseudomonas infection in mice by a burn toxin derived from thermally altered human skin.
    Müller W; Allgöwer M; Städtler K; Burkhart F; Schoenenberger GA
    Res Exp Med (Berl); 1974 Jan; 162(2):153-60. PubMed ID: 4205633
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
    Mansouri E; Blome-Eberwein S; Gabelsberger J; Germann G; von Specht BU
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):161-6. PubMed ID: 12832120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients.
    Pier GB
    J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
    Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
    Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.